echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JBC: Treating "gel"-like foreign property in the lungs can help treat Covid-19.

    JBC: Treating "gel"-like foreign property in the lungs can help treat Covid-19.

    • Last Update: 2020-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    8, 2020 /---/ --- In some patients who die of severe COVID-19 and respiratory failure, gel-like foreign property forms in the lungs.
    according to a new study by the University of Umeå in Sweden, researchers have determined what the active ingredients are in these foreign ogenes, and because of this, the new findings could now be key to new effective therapies.
    there are already some therapies that can slow down the body's production of gels," said Urban Hellman, a researcher at Umeå University in The University of California, D.C. (Photo source: www.pixabay.com).
    our findings may also explain why cocoon seems to have had an effect on COVID-19.
    when lung scans were performed on severe patients with COVID-19 infections, medical professionals were able to see white plaques.
    , autopsy results from some of the deceased's COVID-19 patients showed that the lungs were filled with transparent liquid gel, much like those of a drowning person.
    previously unknown source.
    now researchers have shown that the gel-like foreign body is made up of hyaluracid acid, a polysaccharide in the glycamine polysaccharide group.
    presence of hyalurinoic acid is normal in the human body, has various functions in different tissues, but usually acts as a useful feature in connective tissue.
    particularly important is that acetyl hyaluracin is involved in the early stages of wound healing.
    hyaluric acid can also be synthesized in the beauty industry for lip and anti-wrinkle treatments.
    , because hyaluric acid can bind a large amount of water in its long molecular network, it forms a gel-like substance.
    is precisely the process that causes commotion in the vesicles of COVID-19 patients, causing them to need ventilator care and, in the worst case, to die of respiratory failure.
    , a drug called Hymecromone is used to slow the production of hyalurinoic acid in other diseases, such as gallbladder attacks.
    also has an enzyme that effectively breaks down hyalurinoic acid.
    , for example, can be used in cases where unsuccessful cosmetic treatments need to be terminated immediately.
    also reduces the production of hyaluronic acid.
    in a British study, preliminary data showed that patients with severe COVID-19 had a positive effect on the treatment of the available pine drug dexomethason.
    " had previously been thought to be associated with the general anti-inflammatory properties of the available pine, but in addition to these, the cortisol may also reduce the production of hyaluronic acid, which may reduce the number of gels in the lungs.
    ," Urban Hellman said.
    (bioon.com) Source: Liquid gel in COVID patients' lungs makes way for new treatment Original source: Urban Hellman et al, Presence of hyaluronan in lung alveoli in severe Covid-19 - an opening for new treatment options?, Biological Journal of Chemistry (2020). DOI: 10.1074/jbc. AC120.015967.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.